Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.44 | 2.44 | 0.00 |
Stocks | 97.56 | 97.56 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.36 | 23.73 |
Price to Book | 2.89 | 4.73 |
Price to Sales | 1.50 | 3.56 |
Price to Cash Flow | 12.38 | 16.61 |
Dividend Yield | 2.48 | 1.24 |
5 Years Earnings Growth | 10.57 | 13.32 |
Name | Net % | Category Average |
---|---|---|
Industrials | 25.30 | 12.06 |
Consumer Defensive | 17.68 | 6.54 |
Consumer Cyclical | 14.40 | 12.28 |
Technology | 13.04 | 28.41 |
Healthcare | 10.39 | 15.23 |
Communication Services | 8.76 | 8.62 |
Basic Materials | 5.31 | 3.97 |
Financial Services | 5.12 | 14.05 |
Number of long holdings: 35
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Otra Rv Cotizada En Usd | - | 17.01 | - | - | |
Otra Rv Cotizada En Eur | - | 6.00 | - | - | |
Otra Rv Cotizada En Dkk | - | 4.20 | - | - | |
ASML Holding | NL0010273215 | 3.67 | 725.30 | -1.17% | |
Deutsche Boerse | DE0005810055 | 3.50 | 225.500 | -1.40% | |
Heineken | NL0000009165 | 3.50 | 64.98 | -3.36% | |
Booking | US09857L1089 | 2.96 | 4,726.90 | -2.99% | |
Roche Holding Participation | CH0012032048 | 2.91 | 267.20 | -1.69% | |
Reckitt Benckiser | GB00B24CGK77 | 2.83 | 4,950.0 | +0.55% | |
ASM | NL0000334118 | 2.79 | 593.80 | +0.13% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bestinfond FI | 1.54B | 12.82 | 5.47 | 6.45 | ||
Bestinver Internacional FI | 1.35B | 14.25 | 5.36 | 6.96 | ||
Bestvalue FI | 373.28M | 13.03 | 5.90 | 6.47 | ||
ES0112763000 | 204.47M | 22.84 | - | - | ||
Bestinver Bolsa FI | 151.31M | 9.03 | 8.62 | 5.55 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review